Research ArticleHuman Studies
Pharmacokinetics of Rhenium-186 After Administration of Rhenium-186-HEDP to Patients with Bone Metastases
J.M.H. de Klerk, A. van Dijk, A.D. van het Schip, B.A. Zonnenberg and P.P. van Rijk
Journal of Nuclear Medicine May 1992, 33 (5) 646-651;
J.M.H. de Klerk
A. van Dijk
A.D. van het Schip
B.A. Zonnenberg


This is a PDF-only article. The first page of the PDF of this article appears above.
In this issue
Pharmacokinetics of Rhenium-186 After Administration of Rhenium-186-HEDP to Patients with Bone Metastases
J.M.H. de Klerk, A. van Dijk, A.D. van het Schip, B.A. Zonnenberg, P.P. van Rijk
Journal of Nuclear Medicine May 1992, 33 (5) 646-651;
Jump to section
Related Articles
- No related articles found.
Cited By...
- Palliation and Survival After Repeated 188Re-HEDP Therapy of Hormone-Refractory Bone Metastases of Prostate Cancer: A Retrospective Analysis
- Therapeutic Effects of a 186Re-Complex-Conjugated Bisphosphonate for the Palliation of Metastatic Bone Pain in an Animal Model
- 186Re-HEDP in the Treatment of Patients with Inoperable Osteosarcoma
- Bone-Seeking Radionuclides For Therapy
- 99Tcm(V)DMSA scintigraphy in skeletal metastases and superscans arising from various malignancies: diagnosis, treatment monitoring and therapeutic implications
- Bone Uptake Studies in Rabbits Before and After High-Dose Treatment with 153Sm-EDTMP or 186Re-HEDP
- The Placorhen Study: A Double-Blind, Placebo-Controlled, Randomized Radionuclide Study with 186Re-Etidronate in Hormone-Resistant Prostate Cancer Patients with Painful Bone Metastases
- Therapy of Metastatic Bone Pain
- Skeletal Uptake and Soft-Tissue Retention of 186Re-HEDP and 153Sm-EDTMP in Patients with Metastatic Bone Disease
- Marrow-Sparing Effects of 117mSn(4+)Diethylenetriaminepentaacetic Acid for Radionuclide Therapy of Bone Cancer
- Quantitative Bone Single-Photon Emission Computed Tomography for Prediction of Pain Relief in Metastatic Bone Disease Treated With Rhenium-186 Etidronate